Cargando…

Home videos of cystic fibrosis patients using tobramycin inhalation powder: Relation of flow and cough

BACKGROUND: Many cystic fibrosis (CF) patients chronically infected with Pseudomonas aeruginosa are on maintenance tobramycin inhalation therapy. Cough is reported as a side effect of tobramycin inhalation powder (TIP) in 48% of the patients. Objectives of this study were to investigate the associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meerburg, Jennifer J., Albasri, Mehdi, van der Wiel, Els C., Andrinopoulou, Eleni‐Rosalina, van der Eerden, Menno M., Majoor, Christof J., Arets, Hubertus G.M., Heijerman, Harry G.M., Tiddens, Harm A.W.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852538/ https://www.ncbi.nlm.nih.gov/pubmed/31393073 http://dx.doi.org/10.1002/ppul.24467

Ejemplares similares

The radiological diagnosis of bronchiectasis: what's in a name?
por: Tiddens, Harm A.W.M., et al.
Publicado: (2020)

Pharmacokinetics and safety of tobramycin nebulization with the I‐neb and PARI‐LC Plus in children with cystic fibrosis: A randomized, crossover study
por: van Velzen, Annelies J., et al.
Publicado: (2019)

Airway–artery quantitative assessment on chest computed tomography in paediatric primary ciliary dyskinesia
por: Ferraro, Valentina, et al.
Publicado: (2020)

Airway disease on chest computed tomography of preschool children with cystic fibrosis is associated with school‐age bronchiectasis
por: Bouma, Nynke R., et al.
Publicado: (2019)

Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial
por: Stokker, Jason, et al.
Publicado: (2020)

Rapid early increase in BMI is associated with impaired longitudinal growth in children with cystic fibrosis
por: Hak, Sarah F., et al.
Publicado: (2019)

Tobramycin and vestibulotoxicity: retrospective analysis of four cases
por: Vonk, S E M, et al.
Publicado: (2022)

Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans—A Retrospective Cohort Study
por: Meerburg, Jennifer J., et al.
Publicado: (2020)

Assessment of early lung disease in young children with CF: A comparison between pressure‐controlled and free‐breathing chest computed tomography
por: Oudraad, Merel C. J., et al.
Publicado: (2020)

CFTR Modulators: Does One Dose Fit All?
por: van der Meer, Renske, et al.
Publicado: (2021)

Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation
por: Kristensen, Maartje I., et al.
Publicado: (2021)

Paediatric lung imaging: the times they are a-changin'
por: Tiddens, Harm A.W.M, et al.
Publicado: (2018)

Structure and function of small airways in asthma patients revisited
por: van den Bosch, Wytse B., et al.
Publicado: (2021)

Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study
por: Tiddens, Harm A. W. M., et al.
Publicado: (2020)

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2020)

Contrast-to-Noise Ratios for Assessing the Detection of Progression in the Various Stages of Glaucoma
por: Majoor, Juleke E. A., et al.
Publicado: (2019)

Computerised patient-specific prediction of the recovery profile of upper limb capacity within stroke services: the next step
por: Selles, Ruud W, et al.
Publicado: (2021)

Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients
por: Hoppentocht, Marcel, et al.
Publicado: (2016)

Use of Antibiotics for Exacerbations of COPD
por: Daniels, Johannes M.A., et al.
Publicado: (2017)

Histopathology and genetic susceptibility in COVID‐19 pneumonia
por: von der Thüsen, Jan, et al.
Publicado: (2020)

Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation
por: Burghard, Marcella, et al.
Publicado: (2022)

Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
por: Ting, L, et al.
Publicado: (2014)

Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via Inhalation
por: Gauthier, Timothy P., et al.
Publicado: (2015)

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
por: Terpstra, Lotte C., et al.
Publicado: (2022)

Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis
por: Muilwijk, Danya, et al.
Publicado: (2023)

Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
por: Lv, Qianting, et al.
Publicado: (2021)

The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort
por: Oppelaar, Lisa M., et al.
Publicado: (2023)

Do-not-intubate status and COVID-19 mortality in patients admitted to Dutch non-ICU wards
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder
por: Greenberg, Jonathan, et al.
Publicado: (2016)

Does Addition of Tobramycin Powder Reduce Infection Rates After Spine Surgery?
por: Lee, Yu-Po, et al.
Publicado: (2018)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
por: Uttley, Lesley, et al.
Publicado: (2013)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Lung MRI and impairment of diaphragmatic function in Pompe disease
por: Wens, Stephan CA, et al.
Publicado: (2015)

Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study
por: Yuan, Meng, et al.
Publicado: (2020)

Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract
por: Dautzenberg, M. J. D., et al.
Publicado: (2018)

In Vitro Synergy of Cefamandole-Tobramycin Combinations
por: Valenti, August J., et al.
Publicado: (1977)

Tobramycin Nanoantibiotics and Their Advantages: A Minireview
por: Rosalia, Mariella, et al.
Publicado: (2022)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

De immuungecompromitteerde patiënt
por: van der Eerden, M.M.
Publicado: (2011)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
por: Alarfaj, Reem E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m17m81eo80k4hqpeg63nnf1603